Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
Imran Howell(Institute of Cancer Research), Ian Pavord(University of Oxford), Timothy Hinks(University of Oxford), Mona Bafadhel(National Institute for Health and Care Excellence), J. Mark Melhorn(University of Oxford), Mahdi Mahdi(National Institute for Health and Care Research), Maisha Jabeen(University of Oxford), Sanjay Ramakrishnan(The University of Western Australia)
Cited by 9
Related Papers
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
|The Lancet Respiratory Medicine|2015|584
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434
Benralizumab for the Prevention of COPD Exacerbations
|New England Journal of Medicine|2019|329